The American Council of Cannabis Medicine has been quietly working behind the scenes to prepare for a future where cannabis is recognized as legitimate medicine—and reimbursable through health insurance.

The organization currently holds nine seats on a special committee convened by the Health Secretary’s office. They have been tasked with advising President Trump on cannabis efficacy during the research phase tied to the executive order on rescheduling.

Beyond having a front-row seat in shaping federal cannabis policy, the Council is also building the infrastructure to integrate medical cannabis into the U.S. healthcare insurance system.

Today, my guest is Mathew Rothman, Chief Science and Marketing Officer at Cannalnx—the exclusive technology partner to the American Council of Cannabis Medicine, making this integration possible. This month, they’re rolling out a new program through licensed insurance brokers that allows patients to receive monthly reimbursements—typically between $100 and $175—for medical cannabis and related physician visits.

The Innovating Cannabis podcast is produced and hosted by Pam Chmiel, a freelance writer and editor for the Cannabis Industry Journal. 

Get in touch with [email protected].

LinkedIn   Twitter   Instagram

Please like the show to help us reach more listeners🙏🏻

Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.